Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Operating Margin: 2009-2025

Historic Operating Margin for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to -23.70%.

  • Cumberland Pharmaceuticals' Operating Margin fell 505.00% to -23.70% in Q3 2025 from the same period last year, while for Sep 2025 it was -7.90%, marking a year-over-year increase of 2137.00%. This contributed to the annual value of -16.99% for FY2024, which is 717.00% up from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Operating Margin stood at -23.70% for Q3 2025, which was down 243.61% from -6.90% recorded in Q2 2025.
  • Cumberland Pharmaceuticals' 5-year Operating Margin high stood at 11.03% for Q1 2025, and its period low was -66.07% during Q4 2023.
  • For the 3-year period, Cumberland Pharmaceuticals' Operating Margin averaged around -17.21%, with its median value being -17.65% (2024).
  • Its Operating Margin has fluctuated over the past 5 years, first tumbled by 4,110bps in 2023, then spiked by 4,841bps in 2024.
  • Quarterly analysis of 5 years shows Cumberland Pharmaceuticals' Operating Margin stood at -52.33% in 2021, then spiked by 2,737bps to -24.97% in 2022, then tumbled by 4,110bps to -66.07% in 2023, then surged by 4,841bps to -17.65% in 2024, then tumbled by 505bps to -23.70% in 2025.
  • Its Operating Margin stands at -23.70% for Q3 2025, versus -6.90% for Q2 2025 and 11.03% for Q1 2025.